Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001209191-22-031959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-25 | 2022-05-23 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +12.8K | 12.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-23 | A | A | 6,405 | $0.00 | 9,779 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-23 | A | A | 12,810 | $0.00 | 12,810 | D | $24.14 · 2023-05-23 to 2032-05-22 | 12,810 Common Stock |